As of 2023, hospital discharges for leiomyoma of the uterus in the UK stood at approximately 17.26 thousand. The forecast from 2024 to 2028 shows a declining trend, with a gradual year-on-year decrease in hospital discharges. From 2024 to 2025, there is a forecasted decrease of about 1.11%, followed by similar declines in subsequent years: 1.13% in 2026, 1.08% in 2027, and 1.09% in 2028. The compound annual growth rate (CAGR) over this five-year period is projected to be -1.09%.

Future trends to watch for:

Advancements in non-surgical treatments and outpatient alternatives may further reduce hospital discharges.
Increased awareness and early detection could impact the incidence rate, potentially influencing discharge statistics.
Changes in healthcare policies and funding may affect accessibility to treatment, altering future discharge trends.